Mp. Cohen et al., TREATMENT WITH ACARBOSE, AN ALPHA-GLUCOSIDASE INHIBITOR, REDUCES INCREASED ALBUMIN EXCRETION IN STREPTOZOTOCIN-DIABETIC RATS, General pharmacology, 26(6), 1995, pp. 1355-1361
1. We examined the effect of the alpha-glucosidase inhibitor acarbose
on urinary albumin excretion (UAE) in streptozotocin diabetic rats. 2.
Treatment with acarbose for 8 weeks after induction of diabetes preve
nted the significant increase in UAE observed in untreated diabetic ra
ts relative to nondiabetic controls. 3. Acarbose significantly reduced
integrated glycemia, which correlated with albumin excretion rates, a
nd exerts a salutary effect on diabetic renal dysfunction.